株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のリウマチ治療薬市場規模調査:疾病タイプ別、薬剤タイプ別、流通経路別、および地域別予測

Global Rheumatology Therapeutics Market Size study, by Disease Type, by Drug Type, by Distribution Channel and Regional Forecasts 2019-2026

発行 Bizwit Research & Consulting LLP 商品コード 876670
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
世界のリウマチ治療薬市場規模調査:疾病タイプ別、薬剤タイプ別、流通経路別、および地域別予測 Global Rheumatology Therapeutics Market Size study, by Disease Type, by Drug Type, by Distribution Channel and Regional Forecasts 2019-2026
出版日: 2019年06月25日 ページ情報: 英文
概要

当レポートでは世界のリウマチ治療薬市場について調査しており、市場機会、疾病タイプ・薬剤タイプ・流通経路・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • 主要傾向
  • 全体およびセグメント別市場予測
    • 疾病タイプ別
    • 薬剤タイプ別
    • 流通経路別
    • 地域別
  • 調査方法
  • 調査の前提条件

第2章 リウマチ治療薬市場の定義と範囲

  • 研究の目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 研究のために考慮された年
  • 通貨レート

第3章 リウマチ治療薬市場のダイナミクス

  • シーソー分析
    • 市場成長要因
    • 市場の課題
    • 市場機会

第4章 リウマチ治療薬市場の業界分析

  • ポーターのファイブフォース分析
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 新規参入の脅威
    • 代用品の脅威
    • 業界内の競争
    • ポーターのファイブフォース分析への未来的アプローチ
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
  • 主な購入基準(オンデマンド)
  • 規制の枠組み(オンデマンド)
  • 投資/導入シナリオ(オンデマンド)
  • アナリストの提言と結論

第5章 リウマチ治療薬市場:疾病タイプ別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • リウマチ治療薬市場、サブセグメント分析
    • 慢性関節リウマチ
    • 強直性脊椎炎
    • 変形性関節症
    • ループス
    • 痛風
    • その他

第6章 リウマチ治療薬市場:薬剤タイプ別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • リウマチ治療薬市場、サブセグメント分析
    • 非ステロイド系抗炎症薬(NSAID)
    • 鎮痛薬
    • 疾患修飾性抗リウマチ薬(DMARD)
    • コルチコステロイド
    • その他

第7章 リウマチの治療薬市場:流通経路別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • リウマチ治療薬市場、サブセグメント分析
    • 小売薬局
    • オンライン薬局
    • 病院
    • その他

第8章 リウマチ治療薬市場:地域別

  • リウマチ治療薬市場、地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • その他の欧州
  • アジア
    • 中国
    • インド
    • 日本
    • その他のアジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の世界の地域
    • 南米
    • 中東およびアフリカ

第9章 競合情勢

  • 企業の市場シェア(データの入手可能性別)
  • トップ市場戦略
  • 企業プロファイル
    • AbbVie
    • Pfizer
    • Bristol-Myers Squibb Company
    • Merck & Co.
    • Amgen
    • Janssen Biotech
    • Novartis AG
    • Genentech
    • 武田薬品工業株式会社
    • Sanofi

第10章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場予測
    • 検証
    • 出版
    • 調査の前提条件
図表

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF RHEUMATOLOGY THERAPEUTICS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF RHEUMATOLOGY THERAPEUTICS MARKET
  • TABLE 3. RHEUMATOLOGY THERAPEUTICS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISEASE TYPE 2016-2026 (USD BILLION)
  • TABLE 8. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DRUG TYPE 2016-2026 (USD BILLION)
  • TABLE 9. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
  • TABLE 10. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 52. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 67. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 72. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 77. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 96. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 101. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 102. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 103. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 106. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 107. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 108. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 110. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. RHEUMATOLOGY THERAPEUTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. RHEUMATOLOGY THERAPEUTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. RHEUMATOLOGY THERAPEUTICS MARKET, KEY TRENDS 2017
  • FIG 5. RHEUMATOLOGY THERAPEUTICS MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. RHEUMATOLOGY THERAPEUTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. RHEUMATOLOGY THERAPEUTICS MARKET, PEST ANALYSIS
  • FIG 8. RHEUMATOLOGY THERAPEUTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. RHEUMATOLOGY THERAPEUTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 33. EUROPE RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 34. ASIA PACIFIC RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 35. LATIN AMERICA RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 36. RHEUMATOLOGY THERAPEUTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
目次

Global Rheumatology Therapeutics Market valued approximately USD 44.38 billion in 2018 is anticipated to grow with a healthy growth rate of more than 2.73% over the forecast period 2019-2026. The Rheumatology Therapeutics Market is continuously growing in the global scenario at significant pace. Rheumatology therapeutics market consists of therapeutics used for the treatment of rheumatic disorders, which include rheumatoid arthritis, juvenile rheumatoid arthritis, spondylarthritis, systemic lupus erythematosus, and systemic sclerosis. It is also associated with pain disorders in joints, ligaments and muscles. Rising incidence of rheumatology diseases, rising geriatric population worldwide are the substantial driving factors of the market during the forecast period. Additionally, increasing awareness regarding diseases remittances therapies and growing healthcare expenditure are another factor that impelling the demand of rheumatology therapeutics across the globe. Moreover, technological advancements in pharmaceutical field and increasing investments in healthcare industry for research and development activities are the factors that likely to create numerous opportunity in the near future. However, high capital investment in drug development and presence of alternative such as biosimilar are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Rheumatology Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to rising geriatric population, growing healthcare expenditure and high adoption of biopharmaceuticals for the treatment in the region. Europe is estimated to grow at significant growth rate in the global Rheumatology Therapeutics market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to increasing prevalence of rheumatology diseases and rising number of patient population across the region.

The major market player included in this report are:

AbbVie

Pfizer

Bristol-Myers Squibb Company

Merck & Co.

Amgen

Janssen Biotech

Novartis AG

Genentech

Takeda Pharmaceutical

Sanofi

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

Rheumatoid Arthritis

Ankylosing Spondylitis

Osteoarthritis

Lupus

Gout

Others

By Drug Type:

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Analgesics

Disease Modifying Anti-Rheumatic Drugs (DMARDs)

Corticosteroids

Others

By Distribution Channel:

Retail Pharmacy

Online Pharmacy

Hospitals

Others

By Regions:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Rheumatology Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Rheumatology Therapeutics Market, by Disease Type, 2016-2026 (USD Billion)
    • 1.3.2. Rheumatology Therapeutics Market, by Drug Type, 2016-2026 (USD Billion)
    • 1.3.3. Rheumatology Therapeutics Market, by Distribution Channel, 2016-2026 (USD Billion)
    • 1.3.4. Rheumatology Therapeutics Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Rheumatology Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Rheumatology Therapeutics Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Rheumatology Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Rheumatology Therapeutics Market, by Disease Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Rheumatology Therapeutics Market, Sub Segment Analysis
    • 5.4.1. Rheumatoid Arthritis
      • 5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.2. Ankylosing Spondylitis
      • 5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.3. Osteoarthritis
      • 5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.4. Lupus
      • 5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.5. Gout
      • 5.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Rheumatology Therapeutics Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Rheumatology Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.2. Analgesics
      • 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.3. Disease Modifying Anti-Rheumatic Drugs (DMARDs)
      • 6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.4. Corticosteroids
      • 6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Rheumatology Therapeutics Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Key Market Players
  • 7.4. Rheumatology Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Retail Pharmacy
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. Online Pharmacy
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Hospitals
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Rheumatology Therapeutics Market, by Regional Analysis

  • 8.1. Rheumatology Therapeutics Market, Regional Market Snapshot (2016-2026)
  • 8.2. North America Rheumatology Therapeutics Market Snapshot
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.4. Distribution Channels breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.3. Europe Rheumatology Therapeutics Market Snapshot
    • 8.3.1. U.K.
      • 8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.3. Rest of Europe
      • 8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.4. Asia Rheumatology Therapeutics Market Snapshot
    • 8.4.1. China
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.2. India
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.4. Rest of Asia Pacific
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.5. Latin America Rheumatology Therapeutics Market Snapshot
    • 8.5.1. Brazil
      • 8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.5.2. Mexico
      • 8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.6. Rest of The World
    • 8.6.1. South America
      • 8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.6.2. Middle East and Africa
      • 8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Competitive Intelligence

  • 9.1. Company Market Share (Subject to Data Availability)
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. AbbVie
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial (Subject to Data Availability)
      • 9.3.1.3. Summary
      • 9.3.1.4. Recent Developments
    • 9.3.2. Pfizer
    • 9.3.3. Bristol-Myers Squibb Company
    • 9.3.4. Merck & Co.
    • 9.3.5. Amgen
    • 9.3.6. Janssen Biotech
    • 9.3.7. Novartis AG
    • 9.3.8. Genentech
    • 9.3.9. Takeda Pharmaceutical
    • 9.3.10. Sanofi

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
    • 10.1.6. Research Assumption
Back to Top